← All Xeris Biopharma Holdings, INC filings

Xeris Biopharma Holdings, INC Form 4 insider transactions

NASDAQ
XERS
Xeris Biopharma Holdings, INC
Form 4: Xeris Biopharma Director John Johnson Acquires Shares Following Milestone Achievement
Director John Johnson acquired 89,571 shares of Xeris Biopharma Holdings, Inc. common stock due to the achievement of a Keveyis sales milestone.
NASDAQ
XERS
Xeris Biopharma Holdings, INC
Form 4: Xeris Biopharma Director Exercises Options and Sells Shares
Director John Johnson exercised stock options and sold shares of Xeris Biopharma Holdings, Inc. on March 18, 2024.
NASDAQ
XERS
Xeris Biopharma Holdings, INC
Form 4: Xeris Biopharma Holdings Director John P. Schmid Acquires Additional Shares
Director John P. Schmid of Xeris Biopharma Holdings, Inc. reports purchasing 4,500 shares of common stock at $2.16 per share.